DK0434094T3 - Fremgangsmåder til anvendelse af 2-isopropyl-2-phenylaminovaleronitriler som immunosuppressorer og vasodilatatorer - Google Patents

Fremgangsmåder til anvendelse af 2-isopropyl-2-phenylaminovaleronitriler som immunosuppressorer og vasodilatatorer

Info

Publication number
DK0434094T3
DK0434094T3 DK90125244.5T DK90125244T DK0434094T3 DK 0434094 T3 DK0434094 T3 DK 0434094T3 DK 90125244 T DK90125244 T DK 90125244T DK 0434094 T3 DK0434094 T3 DK 0434094T3
Authority
DK
Denmark
Prior art keywords
immunosuppressors
isopropyl
cyclosporin
phenylaminovaleronitriles
vasodilators
Prior art date
Application number
DK90125244.5T
Other languages
English (en)
Inventor
Richard Aug Mueller
Kearn John P Mc
Terry B Strom
Kenneth J Wieder
Liang Chi-Dean
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of DK0434094T3 publication Critical patent/DK0434094T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C07C255/43Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms the carbon skeleton being further substituted by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK90125244.5T 1989-12-21 1990-12-21 Fremgangsmåder til anvendelse af 2-isopropyl-2-phenylaminovaleronitriler som immunosuppressorer og vasodilatatorer DK0434094T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45600789A 1989-12-21 1989-12-21

Publications (1)

Publication Number Publication Date
DK0434094T3 true DK0434094T3 (da) 1993-08-16

Family

ID=23811068

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90125244.5T DK0434094T3 (da) 1989-12-21 1990-12-21 Fremgangsmåder til anvendelse af 2-isopropyl-2-phenylaminovaleronitriler som immunosuppressorer og vasodilatatorer

Country Status (10)

Country Link
EP (1) EP0434094B1 (da)
JP (1) JPH04210632A (da)
AT (1) ATE87614T1 (da)
CA (1) CA2033038A1 (da)
DE (1) DE69001240T2 (da)
DK (1) DK0434094T3 (da)
ES (1) ES2054207T3 (da)
GR (1) GR3008320T3 (da)
IE (1) IE64870B1 (da)
PT (1) PT96283A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2170050T1 (sl) 2007-06-20 2014-12-31 Milestone Pharmaceuticals Inc. Fenilalkilaminski blokatorji kalcijevih kanalov s kratkotrajnim delovanjem in njihova uporaba

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
ATE87614T1 (de) 1993-04-15
DE69001240T2 (de) 1993-08-05
JPH04210632A (ja) 1992-07-31
GR3008320T3 (da) 1993-09-30
PT96283A (pt) 1991-09-30
EP0434094B1 (en) 1993-03-31
EP0434094A1 (en) 1991-06-26
IE64870B1 (en) 1995-09-20
CA2033038A1 (en) 1991-06-22
IE904627A1 (en) 1991-07-17
DE69001240D1 (de) 1993-05-06
ES2054207T3 (es) 1994-08-01

Similar Documents

Publication Publication Date Title
DE69430951D1 (de) Zusammensetzung enthaltend bradykinin zum selektiven offnen von anormalen gehirngewebes kapillaren
DK0735890T3 (da) Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DE68915834D1 (de) Herstellung von T-Zellen und T-Zellmembranen, verwendbar zur Verhütung und Behandlung von Autoimmunkrankheiten.
DK0387867T3 (da) Præparat indeholdende D-cycloserin og D-alanin til forbedring af hukommelse og indlæringsevne eller til behandling af en kognitiv eller psykotisk lidelse
DE69525151D1 (de) Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
ATE49115T1 (de) Haarbehandlungsmittel.
DK0572688T3 (da) Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
ATE152621T1 (de) Behandlungsverfahren kataboler dysfunktion
DK502087A (da) Bindingsinducerende praeparat og fremgangsmaade til inducering af binding mellem dele af levende mineraliseret vaev
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
IT1135158B (it) Procedimento di iniezione e di formazione della miscela,come pure dispositivo per la realizzazione dello stesso
DK472688A (da) Anvendelse af bezafibrat til behandling af diabetes
DE68921908T2 (de) Zell-assoziierte Glucosyltransferase, Antikörper dagegen und eine diese enthaltende Zusammensetzung zur Prophylaxe von Karies.
ATE76579T1 (de) Interferon-zusammensetzungen.
DK0434094T3 (da) Fremgangsmåder til anvendelse af 2-isopropyl-2-phenylaminovaleronitriler som immunosuppressorer og vasodilatatorer
NO20001758L (no) FremgangsmÕter og blandinger for behandling av leddgikt
DE69220939D1 (de) Gegengift immunsera
DK381085D0 (da) Fremgangsmaade og middel til bekaempelse af luseangreb
DE68916777T2 (de) Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
ATE41927T1 (de) Phenylalkylamine - bioregulatoren.
PT91610A (pt) Process for the preparation of compounds for the treatment of arteritis rheumatoidal